Ski, originally identified as a proto-oncogene, serves as a critical regulator in various cellular processes, including cell growth, differentiation, and transformation. It functions as a transcriptional corepressor, exerting its inhibitory effects on gene expression primarily through interaction with chromatin remodeling complexes and transcription factors. Ski exerts its influence on multiple signaling pathways, with its most well-studied role being within the TGF-β (Transforming Growth Factor-beta) pathway. In this context, Ski acts as a negative regulator, counteracting the pro-differentiation and growth inhibitory effects of TGF-β by binding to Smad proteins and preventing their translocation into the nucleus, thereby inhibiting the transcription of target genes. Additionally, Ski can modulate the activity of other transcription factors and signaling cascades, thereby regulating diverse cellular functions.
Activation of Ski involves various regulatory mechanisms that influence its expression, post-translational modifications, and subcellular localization. Transcriptional regulation plays a crucial role in determining Ski levels, with factors such as growth factors, cytokines, and oncogenes influencing Ski expression levels. Post-translational modifications, including phosphorylation and ubiquitination, regulate Ski stability, localization, and activity. For instance, phosphorylation events mediated by protein kinases can either enhance or inhibit Ski activity, depending on the specific residues targeted and the context of cellular signaling. Moreover, interaction with cofactors and binding partners can influence Ski function, facilitating its recruitment to specific genomic loci and modulating its transcriptional repression activity. The dynamic interplay between these regulatory mechanisms finely tunes Ski activity, allowing for precise control of gene expression programs involved in cellular homeostasis and development.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a selective inhibitor of the TGF-beta type I receptor (ALK5). Inhibiting ALK5 can reduce TGF-beta signaling, potentially attenuating SKI-mediated repression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been studied for its potential to inhibit TGF-beta signaling. It may indirectly affect SKI's repression function by modulating the pathway. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been suggested to inhibit TGF-beta signaling. Its effects may indirectly influence SKI-mediated repression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A has been investigated for its effects on TGF-beta signaling. Its use may lead to altered TGF-beta responses and, consequently, SKI-mediated repression. | ||||||